PharmaShots | Incisive News in 3 Shots

Subscribe Now

Active Ankylosing Spondylitis

Eli Lilly's Taltz (ixekizumab) Receives Health Canada's Approval for Active Ankylosing Spondylitis

Eli Lilly's Taltz (ixekizumab) Receives Health Canada's Approval for Active Ankylosing Spondylitis

February 12, 2020

Eli Lilly's Taltz (ixekizumab) Receives Third US FDA's Approval for Active Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis)

Eli Lilly's Taltz (ixekizumab) Receives Third US FDA's Approval for Active Ankylosing Spondylitis (Radiographic Axial Spondyloarth...

August 27, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us